These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 3297960)
21. T cells and thyroid autoimmunity. Tandon N; Weetman AP J R Coll Physicians Lond; 1994; 28(1):10-8. PubMed ID: 8169877 [TBL] [Abstract][Full Text] [Related]
22. Effect of HLA-DR positive thyrocytes on in vitro thyroid autoantibody production. Iwatani Y; Iitaka M; Row VV; Volpé R Clin Invest Med; 1988 Aug; 11(4):279-85. PubMed ID: 3262474 [TBL] [Abstract][Full Text] [Related]
23. Regulation and role of thyroid cell class II antigen expression. Weetman AP Immunol Res; 1986; 5(2):89-96. PubMed ID: 3093609 [No Abstract] [Full Text] [Related]
24. Class II major histocompatibility complex antigen expression and cellular interactions in thyroid glands of Graves' disease. Matsunaga M; Eguchi K; Fukuda T; Kurata A; Tezuka H; Shimomura C; Otsubo T; Ishikawa N; Ito K; Nagataki S J Clin Endocrinol Metab; 1986 Apr; 62(4):723-8. PubMed ID: 3081570 [TBL] [Abstract][Full Text] [Related]
25. Regulation of major histocompatibility class II gene expression in FRTL-5 thyrocytes: opposite effects of interferon and methimazole. Montani V; Shong M; Taniguchi SI; Suzuki K; Giuliani C; Napolitano G; Saito J; Saji M; Fiorentino B; Reimold AM; Singer DS; Kohn LD Endocrinology; 1998 Jan; 139(1):290-302. PubMed ID: 9421427 [TBL] [Abstract][Full Text] [Related]
26. Suppression of HLA class II expression on thyrocytes by interferon-alpha 1. Guerin V; Todd I; Hammond LJ; Bottazzo GF Clin Exp Immunol; 1990 Mar; 79(3):341-5. PubMed ID: 2317942 [TBL] [Abstract][Full Text] [Related]
28. The in vitro regulation of human thyrocyte HLA-DR antigen expression. Weetman AP; Volkman DJ; Burman KD; Gerrard TL; Fauci AS J Clin Endocrinol Metab; 1985 Nov; 61(5):817-24. PubMed ID: 2995430 [TBL] [Abstract][Full Text] [Related]
29. Major histocompatibility class II HLA-DR alpha gene expression in thyrocytes: counter regulation by the class II transactivator and the thyroid Y box protein. Montani V; Taniguchi SI; Shong M; Suzuki K; Ohmori M; Giuliani C; Napolitano G; Saji M; Fiorentino B; Reimold AM; Ting JP; Kohn LD; Singer DS Endocrinology; 1998 Jan; 139(1):280-9. PubMed ID: 9421426 [TBL] [Abstract][Full Text] [Related]
30. Transgenic mice producing major histocompatibility complex class II molecules on thyroid cells do not develop apparent autoimmune thyroid diseases. Li YS; Kanamoto N; Hataya Y; Moriyama K; Hiratani H; Nakao K; Akamizu T Endocrinology; 2004 May; 145(5):2524-30. PubMed ID: 14764636 [TBL] [Abstract][Full Text] [Related]
31. Thyroid-derived epithelial cells acquire alloantigen-presenting capabilities following X-irradiation and class II antigen induction. Czirjak L; Danko K; Gaulton GN; Stadecker MJ Eur J Immunol; 1990 Dec; 20(12):2597-601. PubMed ID: 2176608 [TBL] [Abstract][Full Text] [Related]
32. HLA-DMB expression by thyrocytes: indication of the antigen-processing and possible presenting capability of thyroid cells. Wu Z; Biro PA; Mirakian R; Hammond L; Curcio F; Ambesi-Impiombato FS; Bottazzo GF Clin Exp Immunol; 1999 Apr; 116(1):62-9. PubMed ID: 10209506 [TBL] [Abstract][Full Text] [Related]
33. Antigen presentation by interferon-gamma-treated thyroid follicular cells inhibits interleukin-2 (IL-2) and supports IL-4 production by B7-dependent human T cells. Lombardi G; Arnold K; Uren J; Marelli-Berg F; Hargreaves R; Imami N; Weetman A; Lechler R Eur J Immunol; 1997 Jan; 27(1):62-71. PubMed ID: 9021999 [TBL] [Abstract][Full Text] [Related]
34. Differential effects of human interferon alpha and interferon gamma on xenografted human thyroid tissue in severe combined immunodeficient mice and nude mice. Kawai K; Enomoto T; Fornasier V; Resetkova E; Volpé R Proc Assoc Am Physicians; 1997 Mar; 109(2):126-35. PubMed ID: 9069581 [TBL] [Abstract][Full Text] [Related]
35. Peptides presented in vivo by HLA-DR in thyroid autoimmunity. Muixí L; Alvarez I; Jaraquemada D Adv Immunol; 2008; 99():165-209. PubMed ID: 19117535 [TBL] [Abstract][Full Text] [Related]
36. The effect of staphylococcal enterotoxin B on thyrocyte HLA molecule expression. Fierabracci A; Hammond L; Lowdell M; Chiovato L; Goode AW; Bottazzo GF; Mirakian R J Autoimmun; 1999 Jun; 12(4):305-14. PubMed ID: 10330302 [TBL] [Abstract][Full Text] [Related]
37. Detection of HLA-DR antigens in paraffin-embedded thyroid epithelial cells with a monoclonal antibody. Lloyd RV; Johnson TL; Blaivas M; Sisson JC; Wilson BS Am J Pathol; 1985 Jul; 120(1):106-11. PubMed ID: 3893150 [TBL] [Abstract][Full Text] [Related]
38. Phenothiazine induces de novo MHC class II antigen expression on thyroid epithelial cells. A new mechanism for drug-induced autoimmunity. Takorabet L; Ropars A; Raby C; Charreire J J Immunol; 1995 Apr; 154(7):3593-602. PubMed ID: 7897238 [TBL] [Abstract][Full Text] [Related]
39. Thyrocyte class I and class II upregulation is a secondary phenomenon and does not contribute to the pathogenesis of autoimmune thyroid disease. Yue SJ; Enomoto T; Matsumoto Y; Kawai K; Volpé R Thyroid; 1998 Sep; 8(9):755-63. PubMed ID: 9777745 [TBL] [Abstract][Full Text] [Related]
40. Function of DR-positive thyrocytes from patients with Graves' disease: quantitative analysis of thyroid peroxidase content by fluorescent photometry. Asakawa H; Hanafusa T; Kuma K; Kono N; Tarui S J Clin Endocrinol Metab; 1992 Mar; 74(3):614-8. PubMed ID: 1740495 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]